Current Therapeutic Research
Volume 64, Supplement A , Pages A4-A15, 2003

Single-dose azithromycin for acute otitis media: A pharmacokinetic/pharmacodynamic rationale

  • Constance D. Rothermel, PhD

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Constance D. Rothermel, PhD Director, Clinical Research, Anti-Infectives Pfizer Inc 235 East 42nd Street New York, NY 10017

Pfizer Inc, New York, New York, USA

Accepted 1 July 2003.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0011-393X(03)80013-9

Current Therapeutic Research
Volume 64, Supplement A , Pages A4-A15, 2003

Article Tools